Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock Price

CUPRStock

$1.90−74.50%52W

Market Cap$13.31M

P/E—

PEG Ratio—

Div yield—

Beta0.35

CUPR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-45.72%

Price vs S&P 500 (4W)1.85%

VGM Score27.44

Book Value / Share (Quarterly)$0.26

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-4.12%

Cash Flow / Share (Quarterly)$-0.48

Price vs S&P 500 (YTD)-52.55%

Gross Margin (TTM)-0.36%

Net Profit Margin (TTM)-9118.83%

EPS (TTM)$-2.06

10-Day Avg Trading Volume0.07M

EPS Excl Extra (TTM)$-2.06

EPS (Annual)$-1.43

ROI (Annual)-89.52%

Gross Margin (Annual)-1.30%

Net Profit Margin (5Y Avg)-3306.05%

Cash / Share (Quarterly)$0.16

Revenue Growth QoQ (YoY)3.25%

ROA (Last FY)-54.95%

EBITD / Share (TTM)$-2.12

Operating Margin (TTM)-9352.76%

Cash Flow / Share (Annual)$-0.48

P/B Ratio2.83x

P/B Ratio (Quarterly)0.75x

Net Income / Employee (Annual)$-365,233

Net Interest Coverage (TTM)-39.54x

ROA (TTM)-68.80%

EPS Incl Extra (Annual)$-1.43

Current Ratio (Annual)2.35x

Quick Ratio (Quarterly)1.11x

3-Month Avg Trading Volume2.17M

52-Week Price Return-74.50%

Revenue / Employee (TTM)$5,706

P/S Ratio (Annual)287.13x

Asset Turnover (Annual)0.01x

52-Week High$11.57

Operating Margin (5Y Avg)-3433.66%

EPS Excl Extra (Annual)$-1.43

26-Week Price Return-35.81%

Quick Ratio (Annual)1.11x

13-Week Price Return-52.14%

Total Debt / Equity (Annual)0.03x

Current Ratio (Quarterly)2.35x

Enterprise Value$8.89M

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$3,908

Inventory Turnover (Annual)58.43x

Pretax Margin (Annual)-9240.53%

Cash / Share (Annual)$0.16

3-Month Return Std Dev142.41%

Gross Margin (5Y Avg)20.69%

Net Income / Employee (TTM)$-519,674

ROE (Last FY)-92.44%

Net Interest Coverage (Annual)-291.09x

EPS Basic Excl Extra (Annual)$-1.43

Receivables Turnover (TTM)3.27x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-2.06

Receivables Turnover (Annual)2.24x

P/S Ratio (TTM)196.47x

Pretax Margin (5Y Avg)-3249.85%

Revenue / Share (Annual)$0.02

Price vs S&P 500 (52W)-90.03%

Year-to-Date Return-40.63%

5-Day Price Return-7.77%

EPS Normalized (Annual)$-1.43

ROA (5Y Avg)-69.14%

Net Profit Margin (Annual)-9367.51%

Month-to-Date Return-16.67%

EBITD / Share (Annual)$-1.47

Operating Margin (Annual)-9680.96%

LT Debt / Equity (Annual)0.03x

LT Debt / Equity (Quarterly)0.03x

EPS Basic Excl Extra (TTM)$-2.06

P/B Ratio (Annual)0.75x

Inventory Turnover (TTM)84.59x

Pretax Margin (TTM)-8997.97%

Book Value / Share (Annual)$0.26

Price vs S&P 500 (13W)-54.83%

Beta0.35x

Revenue / Share (TTM)$0.02

52-Week Low$1.13

gGradeD

mGradeF

vgmGradeD

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Ltd specializes in chronic wound management through its MEDIFLY product line, which uses sterile blowfly larvae as a biological debridement tool. MEDIFLY offers a clinically proven alternative to traditional surgical debridement for chronic wounds. The company also operates in the health and beauty sector.